Cancer Burden in Bangladesh: Insights From National Institute of Cancer Research & Hospital, 2014-2020
- 1 March 2026
- journal article
- Published by American Society of Clinical Oncology (ASCO) in JCO Global Oncology
- Vol. 12 (3) , e2500584
Abstract
PURPOSE: Bangladesh, a lower-middle–income country in South Asia, faces a rapidly rising cancer burden. In the absence of a population-based cancer registry (PBCR), monitoring national patterns remains challenging and constrains evidence-informed policymaking. We analyzed temporal trends in cancer distribution at the country's largest national cancer hospital to inform priorities for a cancer control strategy. METHODS: We conducted a retrospective analysis of 82,209 histologically and/or clinically confirmed cancer cases diagnosed or treated at the National Institute of Cancer Research & Hospital, between January 2014 and December 2020. Demographic and clinical data were extracted from hospital records, and cancers were grouped according to their primary anatomic site. Annual distributions and sex-specific patters of the 10 most common cancers were examined, and temporal changes were illustrated using trend diagrams. RESULTS: Over 7 years, the most common cancers were of the respiratory system (19.6%-22.5%), digestive organs (18.8%-22.8%), and breast (12%-14.9%). Comparison between 2014 and 2020 revealed notable increases in the proportion of digestive organ cancers (+3.6%), hematopoietic and reticuloendothelial malignancies (+1%), and breast cancer (+0.8%), whereas respiratory cancers (–2.3%), lymph node cancers (–1.1%), and bone and cartilage cancers (–1%) decreased. A marked spike in female genital cancers was observed in 2015 (11.84% v 9.9% average across other years). Findings should be interpreted in the context of hospital-based case mix and referral patterns. CONCLUSION: In this large tertiary cancer hospital in Bangladesh, respiratory system, digestive organ, and breast cancers represented the highest burden, with rising proportions of proportional increases in digestive, hematopoietic, and breast cancers and declines in respiratory and lymph node cancers, provide early signals of an evolving cancer landscape. While not population-representative, these trends highlight the urgent need to establish government-supported PBCRs in well-defined subnational regions to inform effective cancer control strategies for Bangladesh.Keywords
This publication has 27 references indexed in Scilit:
- Prevalence of betel nut chewing and its pattern of distribution across the Bangladeshi socio-demographicsScientific Reports, 2025
- Estimating the burden of cancer attributable to tobacco in Bangladesh in 2020Journal of Cancer Policy, 2025
- Cancer incidence and mortality estimates in 2022 in southeast Asia: a comparative analysisThe Lancet Oncology, 2025
- Cancer care and outreach in South Asian Association for Regional Cooperation (SAARC) countries: from epidemiology and the National Cancer Control Programme to screening, diagnosis, and treatmentThe Lancet Oncology, 2024
- Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 studyThe Lancet Regional Health - Southeast Asia, 2024
- The burden of diseases and risk factors in Bangladesh, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Global Health, 2023
- Awareness of breast cancer and barriers to breast screening uptake in Bangladesh: A population based surveyMaturitas, 2016
- Global cancer transitions according to the Human Development Index (2008–2030): a population-based studyThe Lancet Oncology, 2012
- Evaluation of data quality in the cancer registry: Principles and methods Part II. CompletenessEuropean Journal of Cancer, 2009
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001